Article info
PDFCommentary
Clinical applications of circulating HBV RNA as a potential surrogate biomarker for intrahepatic cccDNA transcriptional activity
- Correspondence to Professor Xinxin Zhang, Department of Infectious Diseases, Research Laboratory of Clinical Virology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China; zhangx{at}shsmu.edu.cn; Prof Thomas Berg, Division of Hepatology, Department of Medicine II, University of Leipzig Medical Center, Leipzig, Germany; thomas.berg{at}medizin.uni-leipzig.de
Citation
Clinical applications of circulating HBV RNA as a potential surrogate biomarker for intrahepatic cccDNA transcriptional activity
Publication history
- Received November 10, 2023
- Accepted November 30, 2023
- First published December 11, 2023.
Online issue publication
March 07, 2024
Article Versions
- Previous version (11 December 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.